News | June 10, 2015

Russia's First Private PET Diagnostics, High-accuracy Radiotherapy Departments Open in Moscow

Group of Companies European Medical Center now offers comprehensive oncologic protocol including screening, diagnostics, chemotherapy and radiotherapy

GEMC, PET-CT, pharmaceuticals, Institute of Oncology, radiotherapy, Moscow

June 10, 2015 - In May, Group of Companies European Medical Center (GEMC) became the first private clinic in Russia to open a positron emission tomography (PET-CT) department producing its own pharmaceuticals. GEMC also opened a radiation cancer therapy department featuring two linear accelerators.

GEMC has thus created an Institute of Oncology unprecedented among private clinics in Russia, implementing a comprehensive oncologic protocol - from screening and high-accuracy diagnostics (PET/CT, magnetic resonance imaging, pathomorphology, immunohistochemistry, genetic testing) to chemotherapy and radiotherapy, da Vinci robot-assisted surgery, provision of psychological support for patients and their families, palliative care and pain treatment.

"The project received over ten favorable decisions and permits on security from regulatory bodies and expert organizations. All facilities are equipped with modern radiometric and radiation-monitoring equipment certified in Russia according to national and international standards," stated Leonid Shayman, GEMC board member responsible for the creation of the PET-CT and the Radiation Therapy Departments.

"The main advantage of the equipment is its ability to apply more intense radiation exposure in less time, greatly increasing the effectiveness of treatment, while reducing the length and number of sessions. The department provides round-the-clock emergency radiotherapy for oncologic emergencies, and radiation treatment of cancer in children over three," added Shayman.

The PET-CT and Radiotherapy Center is located at the multifunctional GEMC hospital in Moscow. The total amount invested is 1.35 billion rubles. The annual capacity of PET-CT Diagnostics Center is 6,000 patients; the radiation therapy department capacity is 25,000 patients.

The Department of Radionuclide Diagnostics is equipped with PET-CT and Philips Gemini computed tomography (CT) systems and the single-photon emission computed tomography (SPECT) Philips Brightview XCT system. The department features a cyclotron by IBA that produces its own PET-CT radiopharmaceuticals. The extended quality control laboratory, equipped with the most modern equipment, is operational. A research technique on sentinel lymph node for breast cancer and melanoma is applied. An expansion of radiopharmaceutical production choline and tyrosine applied in oncourology and neurosurgery is planned in autumn 2015.

The Department of Radiotherapy is equipped with TrueBeam and Trilogy linear accelerators by Varian. Treatment is performed by highly skilled professionals trained in radiation therapy in leading clinics in Israel and the United States.

For more information: www.emcmos.ru/en

Related Content

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve.

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve. Getty Images

Feature | Oncology Information Management Systems (OIMS) | May 27, 2020 | By Reshu Gupta
In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive.
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

USask PhD bio-medical engineering student Farley Chicilo at the Canadian Light Source synchrotron at University of Saskatchewan. Photo courtesy of Canadian Light Source, University of Saskatchewan

News | Radiation Therapy | May 14, 2020
May 14, 2020 — An innovative radiation treatment t
Medical University of South Carolina researchers have developed and validated prediction tools, known as nomograms, that could be used to help prevent delays in the initiation of radiotherapy after surgery for head and neck cancer

 

Evan Graboyes, M.D., and his team believe their nomogram tools will improve survival rates for head and neck cancer patients. Photo courtesy of MUSC Hollings Cancer Center

 

News | Radiation Oncology | May 14, 2020
May 14, 2020 — More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs i
Due to ongoing health concerns related to the spread of the Coronavirus (COVID-19) as well as global travel restrictions, the American Association of Physicists in Medicine (AAPM) has decided to evolve the Joint AAPM/COMP (Canadian Organization of Medical Physicists) Meeting content into a virtual (completely online) meeting in place of the in-person meeting originally scheduled for July 12-16, 2020, in Vancouver, BC.
News | AAPM | May 11, 2020
May 11, 2020 — Due to ongoing health concerns related to the spread of the Coronavirus (...
Figure 1: CT image of lesions in different planes

Figure 1: CT image of lesions in different planes.

Sponsored Content | Case Study | Radiation Oncology | April 30, 2020 | By Christopher Bowen, M.S., DABR
360 Photos | 360 View Photos | April 30, 2020
The company .decimal at ASTRO showed a 3-D prin
Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers

Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers. Image courtesy of Dave Tsai/Los Alamos

News | X-Ray | April 24, 2020
April 24, 2020 — Getting an X-ray at the dentist or